UPMC Hillman Cancer Center - Washington — Washington, Pennsylvania

UPMC Hillman Cancer Center - Washington is a clinical research site located in Washington, Pennsylvania, United States 15301.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

UPMC Hillman Cancer Center - Washington has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hillman Cancer Center - Washington?

UPMC Hillman Cancer Center - Washington has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hillman Cancer Center - Washington conducted?

UPMC Hillman Cancer Center - Washington has 3 clinical trials on record, with 3 currently active. Their work covers Uterine Neoplasms, Uterine Cervical Neoplasms, Biliary Tract Neoplasms.

Is UPMC Hillman Cancer Center - Washington accredited by Crixeo Health?

UPMC Hillman Cancer Center - Washington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hillman Cancer Center - Washington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.